Subscriber Discussion

Pros And Cons Of Intentionally Contracting Novel Coronavirus...

U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified

with the first case of community spread of COVID-19 in the U.S., amid growing spread worldwide, it seems inevitable that sooner or later there will be hundreds or thousands of cases all across the country.

people will understandably do everything possible to avoid contracting the virus. though with an estimated transmission rate of around 1:3 (compared to influenza ~1:2), it may just be a matter of time before all but the most hermetic souls are exposed.

**** **** ******* ***** ********** ** lifestyles *** ****** **********.

******* *** *****, ******** ******/******** *** may ** *********, ******* ************.

** *** ***** ****, ***** *** good ****** ****, ** ***** *********, to ******* ****** ********, **** **** of *** ********** ***** *** ***/** people **** ******* **********. ***** *** reports ** **** ************ **********.

** **** ** ********* *** ** immunity **** *** ***** ******* ***** recovery, (*** ***** *** *** *** IFs) *** ***'* ***, *** *** sake ** ********, **** *** **** to * *******, ******* ****** *** the **** ** *********, ***** ** be ****** *** **** ** ************* contract *****-** ** * ********** *******?

****

***** ****, ***** *** **** **** or ***

****

***** ** ******** / **** **** off ** **** / ***** ********* care / ***** **** ********* ********* available

** ******** ***** *********** *** *****

** ******** ***** ************ *** ***** to ******

***** *** ********

******* ** ****** ******** **** *** never ********, *** ********, ** *** once ********

***** **** ******

***** ** ** *** ****, ** there *** ***

** *** ***** ****** **** ************* try ** *** ***** ****** *****? I **.

(9)
UE
Undisclosed End User #2
•Feb 27, 2020

*********** *******. ** * **** ******* and ********* *******, ** ******'* ** the ***** **** *'* **** *****..

U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified
In reply to Undisclosed End User #2

**** ****, *'* *** ******* *** ideal **** ******.

****** ** ** ******* ******** **** everyone **** ** *******, * ***** would ****** ** ** ** ** own *****.

*** ***** *'* **** ** ******, there ** ********* **** **** ** this ***** ** ** **** ***** than *** ****** ***** * **** operating * ******* **** * *** 20 :)

(2)
Avatar
Brian Rhodes
•Feb 27, 2020
IPVMU Certified

(5)
U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified
In reply to Brian Rhodes

*** *** ***** ** ****** ** done ** * **** ********** ******, with ******** ********* ** ***** ****** you *** ***** ******* **.

***** **** ***** **** **** ********, for **** ** * ****** **** :)

(5)
UI
Undisclosed Integrator #3
•Feb 27, 2020

* ** ***. ** * ***** in *** **** **'* ***** **"*, measles *** *** *** ***** *** a *** ** ******* ************* **** their **** ** ***** ***** **** who *** ** ** **** ***** get ** **** ****. **** **** no ********* *** *, ***** **** my ********, ************ *** *** *******. I ******** ***** ****** ********* *** several **** *** * **** ******* it **. * **** **** ***** because * ***** ***** *** ** some *****/***** ** ***** ********** ******** for ********* *******, ******* ******. * wouldn't ** ** *** ****** *** because *'* *** *** **** **** II ******** ****** ** ****** *********** but * *** **** ****** **** welcome ******** ** *** ** **** with. ** ****** ** ******* **** relies ** *** "**'*"

(1)
(2)
JH
John Honovich
•Feb 27, 2020
IPVM

** **** ** ********* *** ** immunity **** *** ***** ******* ***** recovery, (*** ***** *** *** *** IFs) *** ***'* ***, *** *** sake ** ********, **** *** **** to * *******, ******* ****** *** the **** ** *********, ***** ** be ****** *** **** ** ************* contract *****-** ** * ********** *******?

***************, * ***** *** **** ********** a *******? ** *** ***********, ****'* roughly **** ******** **, **? ****** for *** **** **** *** *** to **** ******** :)

(2)
(4)
U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified
In reply to John Honovich

** *** ***********, ****'* ******* **** vaccines **, **?

**** *****. ***** *** * *** the *******?

(1)
(1)
JH
John Honovich
•Feb 27, 2020
IPVM
In reply to Undisclosed #1

***, ***, * **** ***** ** no *******.

* ** ***** ** ***** ** better ** ******** *********** *** **** for * ******* **** ** ****** to **** ***** **** **** ******* of ****** ******* ******** :)

(1)
U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified
In reply to John Honovich

* ** ***** ** ***** ** better ** ******** ***********...

** ******* *** **. * ****** leave *** ***** ** ** ** :)

**** *** *** ** **** ******, already ** ***** *** *****, ********** etc *** **** *******, ***** **** prevalent.

**/**** * *** ***** **** ******* origin ***** ******* ** *******, *** do *** ***** ****** *** ***** to *****?

* ***** *** ******* ******** ** going ** ** ** ****** **** in **** ** ***********, ******* *** close, ********* *** ******** ********* **/**** be *********.

*** *** *** ****? ** ****** for * *******, ******** ***** **** perfect ** *** ******** *******.

** ****** ** * **** **** to **** **** ****.

** *** ********, **** ****** **** contract *** ***** ************, *** **** it, *** **** ********. ******, ***. those ***** **** **-***********, *** ** severely ********. **** **** ** *** for ****.

*** * ***** **** ********** *****, healthy ****** **** **** ***** *** have *** ** ******* *** ********* with ********.

**, **** ***** ** ***** ** such ** ****.

******* *** ****-******, **** *********** *** remdesivir, *** ********, *** ****** ********* now ** ** ***** ****** ** testing.

***** ***** **** **** **** **** as ***** ** ******* ****** ** possible. ***** ** **** ** ******* when *** *** *** ***** ************, but ******** **** *** *******.

***** *** ***** * *** *********** i'm ******, *** * ***** *****'* a **** ****** ****** **** ** self-infecting ** *** **** ****.

** *** *** **** ***** ** pretty **** *** **** * ****** from ***, ******* * ****** **** hand ******* *** ****** ********?

*.*. ***** **** ***** ***** **** up ***** * *** ******** - if ****** ***** ********* ******** ******* Covid *** ******** **** *** ** habit, ** ***** ****** ***** ********* spread *** ***** ** ****.

Avatar
Brian Rhodes
•Feb 27, 2020
IPVMU Certified
In reply to Undisclosed #1

** *** ********, **** ****** **** contract *** ***** ************, *** **** it, *** **** ********.

**% ** ******** *** ******* -- test ******** *****...

(4)
(3)
U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified
In reply to Brian Rhodes

**** ** **'* **** **** ****** can ** *********** ********** *** *** sick *****, ****'* ****** **** **** over :(

*** *** **** ** *** ****** to ******* *** ********** ********, *** apparent **** ** ********, *** *** newness ** *** ********** ****** ** those ******* ***** *** ******** * testing ***********.

**** **************:

"*******" **** **** ***** ******, ***'* hope **** ****'* ***** :)

(2)
UI
Undisclosed Integrator #5
•Feb 27, 2020
In reply to Undisclosed #1

**/**** * *** ***** **** ******* origin ***** ******* ** *******, *** do *** ***** ****** *** ***** to *****?

* **** * ********* *** “** remote ********* / ******* **** ****” policy **** ****** *******.

(2)
ME
Matthew Eckman
•Jul 02, 2020
In reply to John Honovich

******... **** ******* *** ******* ****** is ****. ***** **** ** ***** there ** **** **** ******* ******...

UM
Undisclosed Manufacturer #4
•Feb 27, 2020

*** **** **** **** ******* **, say, ******* ******** ** * ****** deep *********** ** ** ********* ****** somewhere, ********** **** *** ***** *** eating ****** ***** *** ******* *** the **** ** ************? ****** *** a ******.

(1)
(5)
U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified
In reply to Undisclosed Manufacturer #4

*** **** **** **** ******* **, say, ******* ******** ** * ****** deep *********** ** ** ********* ****** somewhere, ********** **** *** ***** *** eating ****** ***** *** ******* *** the **** ** ************

**** ** **** ***

(1)
(3)
JH
John Honovich
•Feb 27, 2020
IPVM

** *** *** * *** ******** that **** ***** ******** ** ****** media ****** ** ***** ** ******** do **** *** *** *********.

(2)
U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified
In reply to John Honovich

**** '**, ****'** ************* *** ****?

Avatar
Brian Rhodes
•Feb 28, 2020
IPVMU Certified
In reply to John Honovich

(1)
(4)
U
Undisclosed #1
•Feb 27, 2020
IPVMU Certified

(3)
U
Undisclosed #1
•Feb 28, 2020
IPVMU Certified

** ** *** ****** ******* ************, the ******* **** **** ** ** extremely ******** *** ******* ***** ***** travel ******* *** **** ** ********* trips *** **** ** ******* ****** members **** ********.

*** **** **** ***** ** ****, since *** ***** *** ** *********** by ****** ****** **** ******* ******** themselves; *** *** ******* *** *** the **** ******** *** ****** ****.

U
Undisclosed #1
•Feb 29, 2020
IPVMU Certified

********* **** * *** ******** *****:

********* ******** ****** ****** ***,*** ****** a **** ** *** *.*. ** need ***************.

********** ** *** ************* ******* *****, the ******** **** *** ***** ***** by ***********, *.*. **** *******, ******** sick ******, ******* **** **** **** should ***** * *********** ********* ** cases **** *** **** ************* ********* virus.

******* **** ***** ****** ** * degree *** ****** ** *** ********** system **** *** *** ***** ***** create.

JH
John Honovich
•Feb 29, 2020
IPVM
In reply to Undisclosed #1

********* ******** ****** ****** ***,*** ****** a **** ** *** *.*. ** need *************** .... ****** ***** * significant ********* ** ***** **** *** less ************* ********* *****.

******* **** ***** ****** ** * degree *** ****** ** *** ********** system **** *** *** ***** ***** create.

**** ** * *** **** ****** cutting *** * *** *** *** benefits ** ****** **** *** *** having ** **** **** *******. **'* true *** *** * *********** ****** offsetting *******.

**** *** **** ******* *** *********** *********** ******* ****************** ********** ***** ** ******** **** ** "******** **** ******* ** ** ** percent ** ****** ** *** ***** will ****** ******** **** *** ***********."

***** *** ******* ** **** ***********, lack ** * *******, ****-***** **********, clinical *******, *** ****** ************, ****** death ****, ***., ** ***** ******* make *** ***,*** ****** *** *** look **** *******, *****/********?

(3)
(1)
U
Undisclosed #1
•Mar 01, 2020
IPVMU Certified
In reply to John Honovich

******, * ****'* ***** **** *******.

***** *** ******* ** **** ***********, lack ** * *******, ****-***** **********, clinical *******, *** ****** ************, ****** death ****, ***., ** ***** ******* make *** ***,*** ****** *** *** look **** *******...

*****, ** ******* *****.

...**** ** * *******, ****-***** **********, clinical *******, *** ****** ************, ****** death ****...

*****, *** **** ***** **** ***** make *** *** **** ****** **** the **** ** ******, ** **** it ******* *** * ******* **** start ** ****** ** **********, **** > *** ******* ********** ********* ** a ****** ******.

*** *'* * ****** ******** ***** you ****

* ** ***** ** ***** ** better ** ******** *********** *** **** for * ******* **** ** ****** to **** ***** **** **** ******* of ****** ******* ******** :)

** ** ** **% *** ***** to *** ** *************** ******* *****, ***** ***** ** an ********* ** ***** ******** ** a ********** ******, ***** *** *** use ****-****** **** *** *** **, assuming *** **** *** *** **** demographic?

****, *** *** ******* * ****** for * ******* ***** ************ ** a ******* *** "***** **** ****", Lepsitch **** ** ******, **** *** most ******** ********* **** ** ** around ** ******.

JH
John Honovich
•Mar 01, 2020
IPVM
In reply to Undisclosed #1

**** ** ******* *** * ******* head ***** ** ****** ** **********

****, *** *********** ********** ***** ******* fairly *******. ********* **** ** **** about '*********** ******' *** **** ** literally * **** ** **** *********** growth, *.*., ***** **** ** ** 100,000 ******** * ***** ** * real *********** (***** **** ******* ********* are ****** **** ** **** ***** etc.).

* **** **** *** ***** **** allusion. ** ******* ***** *** **** time ***** * ******* *********** ** a *******, ***********, ***.

** ** ** **% *** ***** to *** ** *************** ******* *****, ***** ***** ** an ********* ** ***** ******** ** a ********** ******

*** ****** *** ****** * *** for ***** ***, *** *****. * say ***** ****** *** ** ***********, take * *** ***** *** *** then ** *********** *** **** ** the ****.

*** *** ** *, ** ***** strike ** ** * ****** ****** to **** *********** / ****** ********.

U
Undisclosed #1
•Mar 01, 2020
IPVMU Certified
In reply to John Honovich

...* *** ***** ****** *** ** immediately...

* ****** **** ******. *** ** favor, *** *** :)

*******, ***** *** **** ******* *** there, ** ***** ** *** ***** of ****** ** ****** ************.

******* ***********, ****** *******, *******, ****** and **** *******. **** ** ****?

******* ** **** ******** **** ******** is ******** :)

**** ******** **** **. ******** ****, that *** ****** ** *** ***** won't **** ***** ** ***** **% infected, ** ***** ** *** * vaccine. *** ** ****** *** ****** is **** ******.

** ** ** *** ** *** inevitable **% ******* ** ****-********* * large ****** ** ************ *****, *****'* less *********, **?

** ***** ** ** * ***** responsibility *** ***** *** *** ******** with ******* ****/****** ** ** ** for *** ********** ** ***** **** maximum ****...

U
Undisclosed #7
•Mar 01, 2020
In reply to Undisclosed #1

** ***** ** ** * ***** responsibility *** ***** *** *** ******** with ******* ****/****** ** ** ** for *** ********** ** ***** **** maximum ****...

***** ****.

** *** ****-****** ******** **** *** yearly *** *****?

** ***, *** ***?

U
Undisclosed #1
•Mar 01, 2020
IPVMU Certified
In reply to Undisclosed #7

** *** ****-****** ******** **** *** yearly *** *****?

***, * *** * *** **** every **** :)

*** ** ***** *** ** *******, i ***** ******** ***** ******, ** ** ***** **** ** the *** ** *********. *** ***** not **** *** ****, *** * respect ****.

***, ** ******'* **** ******* *********-* is * *********** ******** *****, **** yearly ************ ******* **** ******* ******** within *** ****** ******* ** *** antigenic *****.

** ** * *** ** ** it ***** ****, **.

** *** ***** ****, *****-** *** not ******* *** *** ******** *********** the **** ***** ** *** ***** isolation, (****** ****'* ** ********* ** will *** ******.)

****, ******* ** ********** **-** ***** as ****** ** *** ***.

** ******* ** * ******* ****** had ****** ***** ******* *******/************ ** avoid ******* ** **** ** ********, and **** *** ********* ** ******* them ** ******** **** ****/******** *** generally ****** **** ** **** ***** treatments ***/** ******** ****** *********. *** even ** *** ********** *** ** symptoms, **** ***** ** ******** *** shedding *** *****. **** ******** ***** not **** **** **** **** ****.

** * *** ** **** ********, i ***** * ***** ****** *** it *** *** **** ** ** i ****'* *** **** ****, ** even ***** **** * *****.

***, * ***'* ***** **** **** do ** ***** *** ****** ** becomes ** ****** **** ******** ***** someone *** *** *** ** *** recovered.

** **** ****, *** ********* ** wariness **** ** ****.

**** *** **** ** **** ***** who *** ** ************, *** ********* quickly *** ** ***** *** **'* glad ** *** ** *** *** over **.

***** ****?

:)

UE
Undisclosed End User #8
•Mar 02, 2020
In reply to Undisclosed #1

*** *** **** ******** ****, *********** or ******* ***** ** *** *** virus, ** ***** ** **** **** immune ****** * ******** ** *** current ****** *** *****, ***** ******** the ********** ** **********. ** ** essence ***'** *** ****** ********* ******** with *** *** **** **** (**** you *** * *** ****), ** the **** ***** ****** ********, ****** and *** *** *** ********** ** those ****** ***.

** **** *** ** ***** ********* similar **** ***** **, **** * would ******** ** **.

* *** **** ***** ******, ** I ** ******* *** *******, * could ****** ******, **** ****** **** from ***** *******, ***** ** ***, win (*********), *** **** ** ***** my ***** **** ******* *** **** of *********** ******** ** *** ********* it ****** *** ******* ***-******* ******.

(2)
U
Undisclosed #1
•Mar 02, 2020
IPVMU Certified
In reply to Undisclosed End User #8

*** *** **** ******** ****, *********** or ******* ***** ** *** *** virus...

*****, ***.

********, *********** ************* ****.

*******, *** *** ****-**** ****** ********************* *** ******** * **-****** "****" *****, ***** ******** **** "********, spread" ***.

** *** *****, **** ******* ** my ******** ** ** *** ****** swab-in-cheek, *** * ********** ******** ******* relying ** ** ********* ******.

U
Undisclosed #1
•Mar 02, 2020
IPVMU Certified
U
Undisclosed #1
•Mar 06, 2020
IPVMU Certified
In reply to Undisclosed #1

****, **** ****

UI
Undisclosed Integrator #6
•Feb 29, 2020

*********** ********... *** ***** ** ** my ****!

******* **** *** *** **** * mandatory **** ********* ** **-** ****.

**** **** ** **** *** *’* be ******* *** ********* ***** ** update *’* ** ***** *****!

U
Undisclosed #1
•Feb 29, 2020
IPVMU Certified

*******:

******** *** ****** ** ‘***** *** Parties’

***** ****** **** *** **** ** self-infection **** *** ******* **** ***** flu ****** *** ******** *** ***** doubt **** ***** **** ** ****** effective ******* ** **** *** ***** if ** ******* ** *** ****, especially ** ** ***** ******* ******** with *** **** ****** ** *** picked ** ********** ** *** ********* drug *******. **** ** **** ****** switched ** ****** * ******* ******* a ******** ****** ***, ***** ***** capacity ** ****** ** **** **** one ** *** ******* ***** ** a ****, *** ***** ****** ************ said *********. ****** ********* ***** **** to ** **** ***** ***** ** the *****’* *** ******* ****** *** the *******.

U
Undisclosed #7
•Feb 29, 2020

******** ***** *********** *** * ***** away **** *** ***** ****** *** a ******* ****** ** **, ** way * ***** ****-******... **** ** I *** ***** *** ******.

*** ******** *** **** * ***** hurts *** **** **** ** ** brain, **** ****** *** ****** ** compel ** ** ****** *** ***.

U
Undisclosed #1
•Feb 29, 2020
IPVMU Certified
In reply to Undisclosed #7

******** ***** *********** *** * ***** away **** *** ***** ******...

*** ***********.

**** ***** ** ** **** ***** Covid ********* ********, **** **** **** online. **** **** **** *** *** supplies / *** *********, *** **** importantly, ********** ******** ****** ** ******** with.

U
Undisclosed #1
•Mar 01, 2020
IPVMU Certified

*** ********* ** ***** ** *.*.********** *** ****...

**. ********: * ********* ** * vaccine. *** *- * ***********- * treatment ** ***** ** ** **** likely ** ** ********* ** *** fall. * ******* ** * **** longer *** ***. *** ** ****** knew **** **** **** ** * generation ****** **** *****, *** **** might ** **** ******, **** **** we **** ***** ** **** ** depend ** *** *** ******* *** something ** **** ** **** * treatment ** * *******. * *********, again, ** ***** **** ** *********, October, ***********.

******** *******: *** **** ******* ***** more ******** *******. * ****, ***'** saying ********* ****** *** ****** ** those ***'** **** ********* **** *** virus ** **** ********?

**. ********: **'* ***** ** ********.This- ***** ***, *****'* ******** ******** ** *** ********* ** *****. Everyone's--

******** *******: ******** ** *** ********* of *********** *****--

**. ********: ** *** *.*.--

******** *******: --** *** *.*. **** aren't **** ****'* ******** ***?

**. ********: --**** ****'* ******** ***. It's * *** ******* *- *** million ******, *** ******* ******, ** anyone's ********** **** **- ** ***** very ***. *** ** **** ** get ***** ***** ********* *** ********** so ** *** ***** ******* ****** quarantined *** **** ********* *** ******* more ******. ** **** ** ***** mitigating *** ************ ** *** ******. There *** ** ******** *** ***** by ****** ********, **** **** ********** out ** *** *****, ******* ** the ******* ******* ** ********** *****. And ** ******* ** *** ******* and *** ***** ******* *** ********* strains *** *** ****** *** **** been ********* *****, **'* ********* **** there's ******* ******** *** **** *** thousands ** *****. **'* ** *********** analysis. ***** ******** *** **** *****. We **** ********* ****** *** ** Washington *****, **********, ******* ******** ** Oregon. ** ********* ******** ** *****.

U
Undisclosed #1
•Mar 03, 2020
IPVMU Certified

Should * **** * ****?

*** - ***** ****** *** ** used********* *** ****.

*** - *** *** *** ** aware***** *** ****.

Can * *** ******?

*** - *** **** *** ** tested******** *** ****.

So ****** * **** * ****?

U
Undisclosed #1
•Mar 06, 2020
IPVMU Certified
UE
Undisclosed End User #9
•Mar 06, 2020

***'* **** **** *** ** ****** and ******** ******* *********** *** ***********? This **** *** *** ** **.

(1)
U
Undisclosed #1
•Mar 06, 2020
IPVMU Certified
In reply to Undisclosed End User #9

***'* **** **** *** ** ****** and ******** ******* *********** *** ***********?

***, ******** ** ********** *** ****** to ******* ***** ** *******?

**** **** *** *** ** **.

******* **, *****'* ** *** *** wishes **** **** ** **** ** could *** **** ** ******* *****.

*** **** ******** ******* *** ******** and *** ***** ** * *****.

***'** ********* ********* ** **** ** business ** ********** :)

JH
John Honovich
•Mar 06, 2020
IPVM
In reply to Undisclosed End User #9

**** **** *** *** ** **.

**** ** * ********** *** * think * ****** ******* ***, *** still * ********** ** * ***** that **** ** *** ******** **** very ******** *****. ** *** ** avoided / *******.

*******, *** ****** ********* (****** ************ ********,*** ********,********* ** ********,****** ****** *****, ***.) ** ****** ********* *** from *** ******* ***** **** *** getting, ** **** ******** ** *** industry.

(2)
JH
John Honovich
•Mar 06, 2020
IPVM

*********** #*: **** ** * ************* contracted ***********?

**** ********: **** ** ****,*****:

JH
John Honovich
•Mar 08, 2020
IPVM

**** **** *********:

(1)
U
Undisclosed #1
•Mar 09, 2020
IPVMU Certified
UI
Undisclosed Integrator #5
•Mar 09, 2020
In reply to Undisclosed #1

*** ** ***** *** * *** on *********** ***?

*. ** *** ***** **** ** is.

*. ** ******** * ************.

*. *** ***** ** *** ****** it **** ************ ***** *** *****.

*. ** ** **** ** ** a *********** ***** ** ********* **** is *** ** *** *******.

(1)
(1)
U
Undisclosed #1
•Mar 09, 2020
IPVMU Certified
In reply to Undisclosed Integrator #5

*. ** *** ***** **** ** is.

*** **** ***** (** ****** *******) as * **** *** *******, ****** it's **** ******** **** ********* ******* of * ******* ********** ** *** underlying ********.

*. ** ******** * ************.

***. ** **** ********** ** *** when ********, *** *****.

*. *** ***** ** *** ****** it **** ************ ***** *** *****.

**, ****** **** * ********** ********** would ** ******* *** *** ********* at **** *****.

*. ** ** **** ** ** a *********** ***** ** ********* **** is *** ** *** *******.

*** ** *** ******* ****** ******* worldwide, ** ** ***** ** ***** up ** *** ****** ** ****** organizations.

*** **** ****** *****. ** * cost ** **** * **** *** dose.

*** ***** **'* ***** ********* ******, i ****** ***** ** "***".

** *** ***** ****, *** ****** very *********, ********* ***********, ******* ******** antiviral **********, ** ****** ***********, *** will ****** ** ** ***** ******, if *** **** ** ******* ****** available.

*** ***, *********** ***** *********, ** vitro ** *****, **. **********, **** a ********* *****, ******** ** ******:

********** *** *********** *********** ******* *** recently ******* ***** *********** (****-****) ** vitro

*** ********* ** ** ***** ***** that ***** *****'* ****** ***** ** be **** ** ** ***-***** ********, there's ******* ******* **'* ***, *** i ***'* ******* ****'* ****** *** case.

** * *** *** ***** *** there ** ** *** **** ******** yet, * ***** ********* ******** ****** my ****** ** ********* **.

** ** *** *** **, **** is :)

U
Undisclosed #1
•Mar 17, 2020
IPVMU Certified
In reply to Undisclosed #1

******* ***** ***** *********** ***** ***** made ***************, ** **. ******

** *** ***** ** **** ** a ******* ** *********** **** **** like **** ***** ** *******. ** need, *****'* *** ****, *** *******, that's ****, ******************, ***** *** ** fact ** ****** ** * ************ measure... **'** *** ********* ****** ** tried *** **** [******** ***********] ...**** of *** ****** **** ********* ** are ****...*** **********...

U
Undisclosed #1
•Mar 18, 2020
IPVMU Certified
U
Undisclosed #1
•Mar 19, 2020
IPVMU Certified
In reply to Undisclosed #1

*** ***** ** **** * **** ago :)

***** **** ********* ******* ** ******* drug *********** *** *********** *********

U
Undisclosed #1
•Mar 22, 2020
IPVMU Certified
In reply to Undisclosed #1

*** "***" ** *** **:

***** ******** ***’* *** ******* ********** After ********* ***** ****** ******** *********** Treatment

*****’* **** ** *** ****************** ** treat *****-** *** ********* * *** on *** ****. ******* ****** *** stocking ** **** ** **** **** come **** **** *** *******. **** has **** ***** ******** **** ****** and ***** **** ********** ********* ******** confronting * **** ** ********** **** safeguards ****, *** *** **** **** the ******* ** ***** **********. ** they **** ******** ** **** ******** drugs ** ******** ***** ****** *******, it ***** ****** **** *********** ** more ******* ************ ****** **** *** COVID-19.

(1)
U
Undisclosed #1
•Mar 25, 2020
IPVMU Certified
In reply to Undisclosed #1

**, **** ** * ******** *** no *** ***** ***** **** **** 2 ***** ***, **** ** ******:

******* *** ******** ******** *********** ******** by ******* ************* *** ********** *** Their ********

UE
Undisclosed End User #9
•Mar 08, 2020

****

U
Undisclosed #1
•Mar 08, 2020
IPVMU Certified
In reply to Undisclosed End User #9

****** ******* ** *********** **** **** ridiculous **********.

********: *** **** *********************** ***** ************ ******

(3)
U
Undisclosed #1
•Mar 10, 2020
IPVMU Certified

******* ***?

**** *** **** *** *** ** Get ******** **** ***********

U
Undisclosed #1
•Mar 14, 2020
IPVMU Certified

***********: ******* **** ***** ** ** plan *** ‘**** ********’

******* **** **** ***** ** *** government’s ****** ** ******* ***** ******* of *** ******* ********** ***** *********** in * *** ** ****** "**** immunity", ******* ** *** *** **** and ****** ***** ** *********** ** catching ** *****.

*'* ****** *** **** **** **** mean ** "*******" ****** ***** **. the ***** ***** ** ***** ******** as ** **'* ** *********** *** they ***'* ***** *** **** **** do **** ***** **** ********** ** better ******** ******.

U
Undisclosed #10
•Mar 17, 2020

** *** *** **** ****** ****** sit **** *** *** **** ********, sorry ******* ***'** *** *******.

U
Undisclosed #1
•Mar 25, 2020
IPVMU Certified

*** *********** *** ********** ********* ********** ********* Infections

******* **** ******* ** *** ** from * ***** ***...

JH
John Honovich
•Mar 25, 2020
IPVM
In reply to Undisclosed #1

Stopping self-voting. — Steemit

(2)
U
Undisclosed #1
•Mar 25, 2020
IPVMU Certified
In reply to John Honovich

***, **'* **** * **** ****** month :)

U
Undisclosed #1
•Apr 03, 2020
IPVMU Certified

**** *** ***** ****:

****** ****** ******* ***** ***-***-******* ********** to ** ************ ******** **** *********** so **** *** '**** ***** ********* fighting *** ****' ***** **** *******

** *** ****** *** ******* **** the ********** ******** ***** ** '** a ****** ******** ** ***** ** ourselves *** ********, ** ******* **********, to ********** *** ******* ***, *******, join ***** ********* ******** ** ****'.

*** ****** *** *************** ****: '* feel ** ******** ***** ********* ** more ********** **** ** ****** *** others ** **** ******** **** **** dallying ** **** *** ******* ** with ******* ** **** *****.'

U
Undisclosed #1
•Apr 26, 2020
IPVMU Certified

**** ***** *****

***** * “********** *********” ** ********** coronavirus ********** *** **** ******** ******, and **** ***** ******?

** ******, * ******* **** **** a ********* ******, * **** ** *********** ****** that ********* * ***** **** ****** mountaineers ***** ** *** **** *** for **** ********* ** ****-******* *** outbreak ** *** ******* **********: *** public ****** ***** ** “**** ********.”

*** ******** ***** ***** *** ******* of * *********** ******** ** *********** a ******** ** * ********** ** become ******** **** *** *********** *** recover. *** ******** ****** *** * plethora ** *********, ********* *** ******* dilemmas, ******* ****.

U
Undisclosed #1
•Jul 02, 2020
IPVMU Certified

******* ******** ******** '***** *******' ** see *** **** ********

(1)
JH
John Honovich
•Jul 02, 2020
IPVM
In reply to Undisclosed #1

** ***** *** **** *** **** only **** ** ** **** *****, people *** **** ***** *** *******, and **** ********* ******* ***** *** giving ** ** ****** ******* **** group, **'* ******** * ****** ******* to ***** **** ********. *******, * am ******** **** *** ***** ** without ******** **** *******.

U
Undisclosed #1
•Jul 02, 2020
IPVMU Certified
In reply to John Honovich

** ***** *** **** *** **** only **** ** ** **** *****, people *** **** ***** *** *******, and **** ********* ******* ***** *** giving ** ** ****** ******* **** group, **'* ******** * ****** ******* to ***** **** ********. *******, * am ******** **** *** ***** ** without ******** **** *******.

******. ***** **** *** ********* ****** is ******** *** ********.

****, **** ******* *** ****** ***:

IPVM Image

U
Undisclosed #10
•Jul 03, 2020

********** = ****** ***********, ** **** to ********. ***** **** ******. (***?).

**** *****-** **** * *** *******? or * **** ******* **** ******* to ** ********? ******** ***** **-*, mutated *** ****** ************ ** ****** transmission. ***** ****** ***** **** *** Covid-19 ****** *** ***** *** ******** methods ** ***** *** *** ***** cameras, ***** *** ******** *** ** humans **** ***** *** *******, ******** or ********** ******** ************, ****** *** internet ***** ** *** *** *** prescription?

** ****** **** **** ** *** or *****. ***'* *** *** ****** to ****** * ******* **** ****** than ******* *** *** ** ****** sense **** ****** ********** *******.

*********** ** *** *** *** **********...**** the **** *** ***'* **** **** at ***** **** ****** *** ***** from ***. ******* **** ** ** learned *** *** ******* ********** ***** seem ** ** ** *** ***** right ***.

**** ** *** *** *** **** right *** ***** *** ** ***** industry **** **** *****, ********* *** engineering ******** ** *** ** ***** dooms *** *******, ********* *** ***** loops.

***: ** *** *****.

***: **** **** ***.

*******://///

** *** *** ***** *** ***, we **** *** *** *** **** ill. ** *** **** **** ** will *** **** *** *** *** illness, **** ** *** ******* ****. If **** ********* ***** ** ****, you *** ***** ** * ***** or ***** *** ** *** ******** only ** ****** ******* ***** ********* with ** ******** ******** **** ** be **. **** ** *** ******, try ** ********** ** *** **** yourself ***** ** **** ******, ********** or *** ***** **.

U
Undisclosed #1
•Sep 10, 2021
IPVMU Certified
U
Undisclosed #1
•Oct 23, 2021
IPVMU Certified

*** ** ******* **** * ****-**** winner:

****** ****** **** ** *** ***** and *** ****** ** *** ********

***** **** **** ****Dennis ****** informed his audience on Monday that not only does he have Covid-19, but he was ******** *** ******** ** ***** ** achieve “******* ********.”

U
Undisclosed #1
•Nov 27, 2021
IPVMU Certified

*** **’* ************** **…

****-******* ** ***** ****** ** ************ catch *** *********** ******* **** ***** up ** ********* **** ***** ** hospitals *** *** ** **** **** died ***** *********** *** *******, ******* said. * **-****-*** *** **** *** to *********** ** ******* **** **** after ** ********** *** ***** ** what ** ***** ****** * ‘******-*****’ in ***** ***** ** ******** *****. At ***** ***** ****** ********* *** child **** **** ************ *** **** contracted *** ******* ** **** ******* in *****. *** ***** ***** ******** are *** ** ********* ****. ***** who ********** *** ***** *** ******* doing ** *** * ‘***** ****’ which *** *** * *********** ** work ** *****.

***

******* *** **** ******** *** ******* knowingly ******** ** ******* ********** *** get *** ** ****** *** ******* although ******* **** ******** ********* **** this *** ** ***** *** *** seriously ******** ***** ****** ** ****.

******* ********, *********** ** *** **** Covid-19 **** ** ******* **** ***** paper** ************ ****-****** ******* *** **** ****** their ******** ****** ***** *****-** *******.Party ***** **** ** ******* ***** *** ***, **** *** ***** ****** **** ** ******** ******. **** **** ****** ****** * ******* *** ** ***-****** *** *** *** *******-** *** *****.

New discussion

Ask questions and get answers to your physical security questions from IPVM team members and fellow subscribers.

Newest discussions